GenSight Biologics
@gensightbio
A clinical-stage biotechnology company developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system.
ID: 730043770406899712
http://www.gensight-biologics.com 10-05-2016 14:36:13
486 Tweet
1,1K Followers
101 Following
Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: buff.ly/38DQ2ht UPMC University of Basel GenSight Biologics #Ophthalmology #GeneTherapy
Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: buff.ly/38Jeu0Q UPMC University of Basel GenSight Biologics #Ophthalmology #GeneTherapy
Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: buff.ly/3ySs7FE UPMC University of Basel GenSight Biologics #Ophthalmology #GeneTherapy
Join us at Chardan 5th Annual Genetic Medicines Conference #ChardanGMConf #CGMC2021 Bernard Gilly to present on Monday Oct. 4, 2021 8.00am ET. Webcast of the fireside chat to be available at bit.ly/3zZOGsM for 90 days #genetherapy #cellandgenetherapy #rarediseases #LHON
Just published in the peer-reviewed International Ophthalmology Clinics - Bilateral treatment effect following unilateral injection of #genetherapy independently reported by three research groups - LUMEVOQ® for #LHON first #genetherapy requesting #maa #EMA journals.lww.com/internat-ophth…
GenSight Biologics announces that the peer reviewed journal International Ophthalmology Clinics has published a review of all current and past gene therapy trials for LHON. To read more, go to bit.ly/3uOOqfj #Clinicaltrials #LHON
Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: buff.ly/3DZIHHA UPMC University of Basel GenSight Biologics #Ophthalmology #GeneTherapy
La start-up française GenSight Biologics a mis au point une thérapie génique qui redonne leur autonomie aux patients atteints de la maladie de Leber, qui rend quasi-aveugle en quelques semaines nouvelobs.com/economie/20211… récit par Dominique Nora
poc for h1 bc’s LABP-104 gets Approved for #SLE #treatment. #NIH Grant of USD 3 million to Amydis Inc. for exploring #ASYN. #USFDA Grant to GenSight Biologics’ #GS030 for #RetinitisPigmentosa. For more details, visit bit.ly/3mOgWtI. (2/2) #pharma #biotech #news #pharmanews
Fast track designation for GenSight Biologics's gene therapy GS030 businesswire.com/news/home/2021…
Dr Magali Taiel will present at Alliance for Regenerative Medicine (ARM) Cell & Gene Meeting on the Mesa about LUMEVOQ® #genetherapy to treat #lhon #rarediseases #blindness under regulatory review #EMA for European #maa expected in H1 2022 #CGMesa21 #RegenerativeMedicine #retina #ophthalmology
Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: buff.ly/2XaoihT UPMC University of Basel GenSight Biologics #Ophthalmology #GeneTherapy
Magali Taiel of GenSight Biologics discusses LUMEVOQ #genetherapy for Leber hereditary optic neuropathy Watch: 👉 ow.ly/BesJ50Grzd9 👈 Alliance for Regenerative Medicine (ARM) #CGMesa21 #ophthamology #RegenerativeMedicine